Florian Wittlinger

4PUBLICATIONS
13CO-AUTHORS
Biologically active moleculesMolecular targetsSeparation technologies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Dec 03, 2024
Tilting the Scales toward EGFR Mutant Selectivity: Expanding the Scope of Bivalent "Type V" Kinase Inhibitors.

Florian Wittlinger, Surbhi P Chitnis, Calvin D Pham

|Apr 11, 2024
Development of Highly Potent and Selective Covalent FGFR4 Inhibitors Based on SNAr Electrophiles.

Moritz Schwarz, Maksym Kurkunov, Florian Wittlinger

|Dec 15, 2022
Structural Basis for Inhibition of Mutant EGFR with Lazertinib (YH25448).

David E Heppner, Florian Wittlinger, Tyler S Beyett

|Oct 20, 2021
Design of a "Two-in-One" Mutant-Selective Epidermal Growth Factor Receptor Inhibitor That Spans the Orthosteric and Allosteric Sites.

Florian Wittlinger, David E Heppner, Ciric To

Pageof 1